WIPF1 was necessary for MYOCD to promote GC tumor growth by activating the PI3K/AKT signaling pathway
(A) The nude mouse model and subcutaneous tumors in the sh-Ctrl, sh-MYOCD, sh-MYOCD + O-WIPF1, and O-MYOCD + LY294002 groups at 2 and 5 weeks.
(B) The tumor volume was statistically analyzed from 1 to 5 weeks.
(C) The tumor weight was statistically analyzed and plotted in columns.
(D) IHC analysis was performed to determine the protein expression of Ki67 in tissues of the sh-Ctrl, sh-MYOCD, sh-MYOCD + O-WIPF1, and O-MYOCD + LY294002 groups. ∗p < 0.01, ∗∗p < 0.001.